Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Receivables - Other (2020 - 2022)

Historic Receivables - Other for Aptevo Therapeutics (APVO) over the last 3 years, with Q1 2022 value amounting to $3.1 million.

  • Aptevo Therapeutics' Receivables - Other rose 2862.45% to $3.1 million in Q1 2022 from the same period last year, while for Mar 2022 it was $3.1 million, marking a year-over-year increase of 2862.45%. This contributed to the annual value of $3.7 million for FY2021, which is 5466.44% up from last year.
  • Per Aptevo Therapeutics' latest filing, its Receivables - Other stood at $3.1 million for Q1 2022, which was up 2862.45% from $3.7 million recorded in Q4 2021.
  • In the past 5 years, Aptevo Therapeutics' Receivables - Other ranged from a high of $3.7 million in Q4 2021 and a low of $288000.0 during Q2 2020
  • Its 3-year average for Receivables - Other is $2.4 million, with a median of $2.8 million in 2021.
  • In the last 5 years, Aptevo Therapeutics' Receivables - Other surged by 97986.11% in 2021 and then skyrocketed by 2862.45% in 2022.
  • Quarter analysis of 3 years shows Aptevo Therapeutics' Receivables - Other stood at $2.4 million in 2020, then skyrocketed by 54.66% to $3.7 million in 2021, then dropped by 15.01% to $3.1 million in 2022.
  • Its last three reported values are $3.1 million in Q1 2022, $3.7 million for Q4 2021, and $3.1 million during Q3 2021.